Effectiveness of the short-term use of Cimicifuga racemosa in the endothelial function of postmenopausal women: a double-blind, randomized, controlled trial.
- 2019-11-06
- RCT
- Climacteric : the journal of the International Menopause Society 23(3)
- E S Fernandes
- M F S Celani
- M Fistarol
- S Geber
- PubMed: 31691621
- DOI: 10.1080/13697137.2019.1682542
- High evidence
- Adults
The measurements of flow-mediated dilation of the brachial artery, pre and post treatment, respectively, showed a significant increase in patients who used C. racemosa (p=0.006)
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- 160 mg/day